Status:

COMPLETED

Spinal Cord Stimulation for Restoration of Arm and Hand Function in People With Subcortical Stroke

Lead Sponsor:

Lee Fisher, PhD

Collaborating Sponsors:

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Stroke

Brain Diseases

Eligibility:

All Genders

21-70 years

Phase:

NA

Brief Summary

The goal of this study is to verify whether electrical stimulation of the cervical spinal cord can activate muscles of the arm and hand in people with hemiplegia following stroke. Participants will un...

Detailed Description

Specifically, researchers will 1) quantify the motor potentials in arm and hand muscles generated by single pulses of electrical stimulation of the spinal cord using FDA-cleared devices 2) characteriz...

Eligibility Criteria

Inclusion

  • Single, ischemic or hemorrhagic stroke resulting in upper extremity hemiparesis more than 6 months prior to the time of enrollment. (Prior strokes that did not cause upper extremity motor deficits are not exclusionary.)
  • Participants must be between the ages of 21 and 70 years old.
  • Scores higher than 7 and lower than 50 on the Fugl-Meyer scale

Exclusion

  • Serious disease or disorder (ex. neurological condition other than stroke, cancer, severe cardiac or respiratory disease, renal failure, etc.) or cognitive impairments that could affect the ability to participate in study activities.
  • Pregnancy or breast feeding.
  • Receiving anticoagulant, anti-spasticity or anti-epileptic medications throughout the duration of the study.
  • Presence of any implanted medical devices.
  • Severe claustrophobia.
  • Presence of joint contractures deemed by study clinician/investigator to be too severe to participate in study activities
  • Results from the Brief Symptoms Inventory (BSI-18) and additional discussions with the Principal Investigator and a study physician that deem participant inappropriate for the study.
  • Evaluation to sign consent form score \<12.

Key Trial Info

Start Date :

March 24 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2025

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT04512690

Start Date

March 24 2021

End Date

June 30 2025

Last Update

August 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213